[PTGX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
28-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -9.18%
YoY- -95.42%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 0 859 25,722 8,617 10,286 2,265 6,189 -
PBT -31,232 -41,037 -20,930 -36,907 -33,804 -30,842 -23,998 19.18%
Tax -1,071 -406 -181 -832 122 -57 -79 467.65%
NP -30,161 -40,631 -20,749 -36,907 -33,804 -30,842 -23,998 16.44%
Tax Rate - - - - - - - -
Total Cost 30,161 41,490 46,471 45,524 44,090 33,107 30,187 -0.05%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 0.00 -4,730.03 -80.67 -428.30 -328.64 -1,361.68 -387.75 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.62 -0.83 -0.43 -0.77 -0.70 -0.69 -0.54 9.63%
EPS Diluted -0.61 -0.83 -0.43 -0.77 -0.70 -0.69 -0.54 8.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.